Business Description
Cryo-Cell International Inc
NAICS : 621999
SIC : 8099
ISIN : US2288951088
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | -0.18 | |||||
Debt-to-Equity | -0.99 | |||||
Debt-to-EBITDA | -1.05 | |||||
Interest Coverage | 2.82 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -0.56 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.6 | |||||
3-Year EPS without NRI Growth Rate | -26.4 | |||||
3-Year FCF Growth Rate | -46.1 | |||||
3-Year Book Growth Rate | -55.6 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.23 | |||||
9-Day RSI | 68.47 | |||||
14-Day RSI | 67.15 | |||||
6-1 Month Momentum % | -9.01 | |||||
12-1 Month Momentum % | 70.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.42 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 38.58 | |||||
Days Sales Outstanding | 75.14 | |||||
Days Payable | 120.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.2 | |||||
Shareholder Yield % | -7.55 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.07 | |||||
Operating Margin % | 11.14 | |||||
Net Margin % | -30.38 | |||||
FCF Margin % | 4.08 | |||||
ROA % | -14.39 | |||||
ROIC % | 3.57 | |||||
ROC (Joel Greenblatt) % | -67.81 | |||||
ROCE % | -26 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio without NRI | 40.99 | |||||
Shiller PE Ratio | 51.52 | |||||
PS Ratio | 1.99 | |||||
Price-to-Free-Cash-Flow | 49.08 | |||||
Price-to-Operating-Cash-Flow | 6.97 | |||||
EV-to-EBIT | -5.91 | |||||
EV-to-EBITDA | -6.89 | |||||
EV-to-Revenue | 2.29 | |||||
EV-to-FCF | 56.04 | |||||
Price-to-Projected-FCF | 8.12 | |||||
Price-to-Median-PS-Value | 1.1 | |||||
Earnings Yield (Greenblatt) % | -16.92 | |||||
FCF Yield % | 2.07 | |||||
Forward Rate of Return (Yacktman) % | 5.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:CCEL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cryo-Cell International Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 31.344 | ||
EPS (TTM) ($) | -1.14 | ||
Beta | 0.37 | ||
Volatility % | 120.07 | ||
14-Day RSI | 67.15 | ||
14-Day ATR ($) | 0.583012 | ||
20-Day SMA ($) | 6.1245 | ||
12-1 Month Momentum % | 70.03 | ||
52-Week Range ($) | 2.95 - 8.15 | ||
Shares Outstanding (Mil) | 8.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cryo-Cell International Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cryo-Cell International Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Cryo-Cell International Inc Frequently Asked Questions
What is Cryo-Cell International Inc(CCEL)'s stock price today?
When is next earnings date of Cryo-Cell International Inc(CCEL)?
Does Cryo-Cell International Inc(CCEL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |